Basic Information
CinCor Pharma is a developer of targeted therapies for hypertension. The company focuses on cardiovascular, metabolic, and renal diseases. Currently, CinCor Pharma's main product is CIN-107, an enzyme inhibitor designed to target treatment-resistant hypertension.
CinCor Pharma, Inc.
Cincinnati,Ohio,United States of America
less than 15 people
January 01, 2018
info@cincor.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios